TSX Value Picks Including Constellation Software That Investors May Be Undervaluing

As we approach the end of 2025, Canadian markets have shown impressive double-digit gains, with investors closely monitoring central bank meetings and employment data to guide their year-end strategies. In this context of market optimism and economic resilience, identifying undervalued stocks becomes crucial for investors seeking opportunities to enhance their portfolios, particularly in sectors that may benefit from stable interest rates and positive labor market trends.

Advertisement

Top 10 Undervalued Stocks Based On Cash Flows In Canada

NameCurrent PriceFair Value (Est)Discount (Est)
Topicus.com (TSXV:TOI)CA$125.98CA$223.3143.6%
Savaria (TSX:SIS)CA$21.67CA$35.2738.6%
Neo Performance Materials (TSX:NEO)CA$16.71CA$31.4246.8%
kneat.com (TSX:KSI)CA$4.70CA$9.2949.4%
Haivision Systems (TSX:HAI)CA$5.29CA$8.6538.8%
GURU Organic Energy (TSX:GURU)CA$4.75CA$8.9146.7%
EQB (TSX:EQB)CA$96.71CA$189.1548.9%
Dexterra Group (TSX:DXT)CA$11.95CA$22.9047.8%
Decisive Dividend (TSXV:DE)CA$7.12CA$14.1949.8%
Constellation Software (TSX:CSU)CA$3325.82CA$5810.6042.8%

Click here to see the full list of 28 stocks from our Undervalued TSX Stocks Based On Cash Flows screener.

We're going to check out a few of the best picks from our screener tool.

Constellation Software (TSX:CSU)

Overview: Constellation Software Inc. acquires, builds, and manages vertical market software businesses to provide mission-critical solutions for public and private sectors, with a market cap of CA$70.48 billion.

Operations: The company's revenue segment is primarily from Software & Programming, amounting to $11.15 billion.

Estimated Discount To Fair Value: 42.8%

Constellation Software is trading at CA$3325.82, significantly below its estimated fair value of CA$5810.6, presenting a potential opportunity based on cash flows. Despite a high level of debt and recent insider selling, earnings are expected to grow substantially at 23.4% annually, outpacing the Canadian market's growth rate. Recent earnings show revenue increased to US$2.95 billion for Q3 2025 from US$2.54 billion the previous year, with net income rising to US$210 million from US$164 million.

TSX:CSU Discounted Cash Flow as at Dec 2025
TSX:CSU Discounted Cash Flow as at Dec 2025

BRP (TSX:DOO)

Overview: BRP Inc., along with its subsidiaries, is engaged in the design, development, manufacturing, and sale of powersports vehicles and marine products across several countries including Mexico, Canada, Austria, the United States, Finland, Australia, and Germany; it has a market cap of CA$7.78 billion.

Operations: BRP Inc.'s revenue segments include the design, development, manufacturing, and sale of powersports vehicles and marine products in regions such as Mexico, Canada, Austria, the United States, Finland, Australia, and Germany.

Estimated Discount To Fair Value: 17.6%

BRP, trading at CA$106.12, is undervalued compared to its fair value of CA$128.85 based on cash flows. Despite a high debt level, earnings are projected to grow significantly at 21.1% annually, surpassing the Canadian market's growth rate. Recent Q3 results show sales increased to CA$2.25 billion from CA$1.97 billion last year, and net income rose sharply to CA$69.1 million from CA$7.1 million a year ago, highlighting robust financial performance amidst strategic debt management initiatives and collaborations in electrification technology.

TSX:DOO Discounted Cash Flow as at Dec 2025
TSX:DOO Discounted Cash Flow as at Dec 2025

EQB (TSX:EQB)

Overview: EQB Inc., operating through its subsidiary Equitable Bank, offers personal and commercial banking services to retail and commercial clients across Canada, with a market cap of CA$3.63 billion.

Operations: EQB Inc.'s revenue is primarily derived from its banking segment, which generated CA$1.12 billion.

Estimated Discount To Fair Value: 48.9%

EQB, priced at CA$96.71, is significantly undervalued relative to its estimated fair value of CA$189.15 based on discounted cash flow analysis, trading 48.9% below this estimate. Despite a recent quarterly net loss of CA$4.76 million and reduced profit margins from the previous year, EQB's earnings are forecast to grow substantially at 25.1% annually over the next three years, outpacing the Canadian market's growth rate while maintaining a reliable dividend yield of 2.36%.

TSX:EQB Discounted Cash Flow as at Dec 2025
TSX:EQB Discounted Cash Flow as at Dec 2025

Next Steps

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if BRP might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About TSX:DOO

BRP

Designs, develops, manufactures, and sells powersports vehicles and marine products in the United States, Canada, Europe, Asia Pacific, Latin America, and internationally.

Excellent balance sheet and good value.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7719.9% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9217.2% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1907.4% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

FE
PASS3 logo
FernandoLeal on Compass Gas e Energia ·

Compass Gas e Energia has a reliable dividend, with a consistent moat, high free cash flow margins and will expand to two digits net margin.

Fair Value:R$40.9438.2% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.9% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
84 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
192 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0